Pharmacogenomics study shows link between testing and better health outcomes

By Kate McCaffery | September 24 2020 09:37AM

GREEN SHIELD CANADA | Medication | Magazine supplement

Photo: Freepik

“The question we were trying to answer was if clinicians are provided access to pharmacogenomic test results during routine clinical care, would patient outcomes improve?”

This article is reserved to PRO Level subscribers

PRO Level’s multiple privileges

For only $9.95/month

Access to Flash news including: scoops, people on the move, disciplinary decisions, magazine supplements, exclusive reports and financial tables.
Insurance Journal and its original content in paper and digital versions.
Substantial discounts on all of our other products and services, including our annual events.
PRO Level access on Portail-assurance.ca which offers you the same privileges as mentioned above, but in French for the Quebec market.